Gemina Laboratories Ltd. (CSE:GLAB)
 0.3950
 -0.0750 (-15.96%)
  Oct 31, 2025, 9:05 AM EDT
Gemina Laboratories Market Cap
Gemina Laboratories has a market cap or net worth of CAD 30.25 million as of October 31, 2025. Its market cap has increased by 8.55% in one year.
Market Cap 
 30.25M
Enterprise Value 
 30.47M
Revenue 
 10.88K
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
0.40
Market Cap Chart
Since August 11, 2021, Gemina Laboratories's market cap has increased from 21.35M to 30.25M, an increase of 41.66%. That is a compound annual growth rate of 8.60%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 30.25M | -48.86% | 
| Dec 27, 2024 | 59.14M | 49.36% | 
| Dec 29, 2023 | 39.60M | 23.55% | 
| Dec 30, 2022 | 32.05M | 49.59% | 
| Dec 29, 2021 | 21.43M | 0.35% | 
| Aug 11, 2021 | 21.35M | - | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Curaleaf Holdings | 3.04B | 
| Green Thumb Industries | 2.30B | 
| dentalcorp Holdings | 2.18B | 
| Trulieve Cannabis | 1.96B | 
| Sienna Senior Living | 1.81B | 
| Extendicare | 1.34B | 
| Cronos Group | 1.33B | 
| WELL Health Technologies | 1.32B |